• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYSB2101124 精蛋白锌重组赖脯胰岛素混合注射液(25R) Injection Biological Products Supplementary Application 2021-09-13 Lilly France;Eli Lilly Nederland BV view
JYSB2101190 精蛋白锌重组赖脯胰岛素混合注射液(25R) Injection Biological Products Supplementary Application 2021-12-10 Eli Lilly Nederland BV;Eli Lilly Italia SpA view
JYSB2500113 精蛋白锌重组赖脯胰岛素混合注射液(50R) Injection Biological Products Supplementary Application 2025-05-12 Lilly France;Eli Lilly Nederland BV view
JYSB2101051 精蛋白锌重组赖脯胰岛素混合注射液(50R) Injection Biological Products Supplementary Application 2021-06-08 Lilly France;Eli Lilly Nederland BV view
JYSB2101126 精蛋白锌重组赖脯胰岛素混合注射液(50R) Injection Biological Products Supplementary Application 2021-09-08 Lilly France;Eli Lilly Nederland BV view
JYSZ2400014 精蛋白锌重组赖脯胰岛素混合注射液(25R) Injection Biological Products License Renew 2024-03-07 Eli Lilly Nederland BV;Eli Lilly Italia SpA;Lilly Suzhou Pharmaceutical Co Ltd view
JYSB2101016 精蛋白锌重组赖脯胰岛素混合注射液(25R) Injection Biological Products Supplementary Application 2021-04-30 Eli Lilly Nederland BV;Eli Lilly Italia SpA view
JYSB2101125 精蛋白锌重组赖脯胰岛素混合注射液(50R) Injection Biological Products Supplementary Application 2021-09-13 Lilly France;Eli Lilly Nederland BV view
JYSZ2500010 精蛋白锌重组赖脯胰岛素混合注射液(25R) Injection Biological Products License Renew 2025-05-12 Lilly France;Eli Lilly Nederland BV;Lilly Suzhou Pharmaceutical Co Ltd view
JYSB2101192 精蛋白锌重组赖脯胰岛素混合注射液(25R) Injection Biological Products Supplementary Application 2021-12-10 Eli Lilly Nederland BV;Eli Lilly Italia SpA view
CXSS2200070 精蛋白锌赖脯胰岛素混合注射液(25R) Injection Biological Products(3.3) New Drug Application 2022-08-01 Fosun Wanbang (Jiangsu) Pharmaceutical Group Co Ltd view
CYSB2200275 精蛋白锌重组赖脯胰岛素混合注射液(25R) Injection Biological Products Supplementary Application 2022-12-13 Lilly Suzhou Pharmaceutical Co Ltd view
CXSS2200071 精蛋白锌赖脯胰岛素混合注射液(50R) Injection Biological Products(3.3) New Drug Application 2022-08-01 Fosun Wanbang (Jiangsu) Pharmaceutical Group Co Ltd view
JYSB2500114 精蛋白锌重组赖脯胰岛素混合注射液(50R) Injection Biological Products Supplementary Application 2025-05-12 Lilly France;Eli Lilly Nederland BV view
JYSB2101128 精蛋白锌重组赖脯胰岛素混合注射液(50R) Injection Biological Products Supplementary Application 2021-09-13 Lilly France;Eli Lilly Nederland BV view
JYSB2101127 精蛋白锌重组赖脯胰岛素混合注射液(50R) Injection Biological Products Supplementary Application 2021-09-08 Lilly France;Eli Lilly Nederland BV view
JYSZ2200011 精蛋白锌重组赖脯胰岛素混合注射液(50R) Injection Biological Products License Renew 2022-03-10 Lilly France;Eli Lilly Nederland BV;Lilly Suzhou Pharmaceutical Co Ltd view
JYSB2101052 精蛋白锌重组赖脯胰岛素混合注射液(50R) Injection Biological Products Supplementary Application 2021-06-08 Lilly France;Eli Lilly Nederland BV view
CYSB2400163 精蛋白锌重组赖脯胰岛素混合注射液(25R) Injection Biological Products Supplementary Application 2024-06-25 Gan & Lee Pharmaceuticals;Gan&Lee Pharmaceuticals Shandong Co Ltd view
JYSZ2200010 精蛋白锌重组赖脯胰岛素混合注射液(50R) Injection Biological Products License Renew 2022-03-10 Lilly France;Eli Lilly Nederland BV;Lilly Suzhou Pharmaceutical Co Ltd view